New trends in the treatment of type 2 Diabetes Mellitus: a review of Thiazolidinediones, GLP-1 agonists, Dipeptidyl Peptidase-4 inhibitors, and SGLT-2 inhibitors

A tétel rövid nézete
dc.contributor.advisorPórszász, Róbert
dc.contributor.advisordeptDebreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézethu_HU
dc.contributor.authorShokry, Mario Samier Fahmi
dc.contributor.departmentDE--Általános Orvostudományi Karhu_HU
dc.contributor.opponentMegyeri, Attila
dc.contributor.opponentDrimba, László
dc.contributor.opponentdeptDepartment of Pharmacologyhu_HU
dc.contributor.opponentdeptKenézy Kórház, Aneszteziológiai tanszékhu_HU
dc.date.accessioned2014-06-27T12:46:15Z
dc.date.available2014-06-27T12:46:15Z
dc.date.created2014-04-11
dc.date.issued2014-06-27T12:46:15Z
dc.description.abstractThe vast array of medications currently available for treating patients with T2DM has increased substantially. Current investigations clarified novel mechanisms underlying the pharmacokinetic and pharmacodynamic profiles as well as the antidiabetic efficacy of these agents. This article reviews the mechanisms of action of four medication groups currently approved for treating T2DM, with the exception of insulin and its analogues. The article also tries to integrate the mechanisms of the agents to the schema of the pathophysiological factors associated with hyperglycemia in T2DM patients.hu_HU
dc.description.courseáltalános orvoshu_HU
dc.description.courselangangolhu_HU
dc.description.degreeegységes, osztatlanhu_HU
dc.format.extent51hu_HU
dc.identifier.urihttp://hdl.handle.net/2437/194923
dc.language.isoenhu_HU
dc.rights.accessno_restrictionhu_HU
dc.subjectType 2 diabetes mellitushu_HU
dc.subjectoral agentshu_HU
dc.subjectthiazolidinedioneshu_HU
dc.subjectglucagon-like peptide-1 agonistshu_HU
dc.subjectdipeptidyl peptidase-4 inhibitorshu_HU
dc.subjectsodium-glucose transporter-2 inhibitorshu_HU
dc.subject.dspaceDEENK Témalista::Orvostudományhu_HU
dc.titleNew trends in the treatment of type 2 Diabetes Mellitus: a review of Thiazolidinediones, GLP-1 agonists, Dipeptidyl Peptidase-4 inhibitors, and SGLT-2 inhibitorshu_HU
Fájlok
Gyűjtemények
Theses (Faculty of Medicine)